Related Experiment Videos

Portal hypertension vasculopathy--the small intestine, too?

E V Loftus¹, C J Gostout

¹Division of Gastroenterology, Mayo Clinic, Rochester, MN.

The American Journal of Gastroenterology

|May 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.

Digestive diseases and sciences·2024

Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2018

Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.

Alimentary pharmacology & therapeutics·2017

Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study.

Alimentary pharmacology & therapeutics·2017

Immune modulator therapy for microscopic colitis in a case series of 73 patients.

Alimentary pharmacology & therapeutics·2017

Utility of endoscopic therapy in the management of Boerhaave syndrome.

Endoscopy international open·2016

See all related articles